Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IVVD
IVVD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IVVD News
Invivyd Faces Expiration of PEMGARDA Emergency Authorization
2d ago
stocktwits
Invivyd's COVID-19 Monoclonal Antibody Authorization Terminated
2d ago
seekingalpha
Invivyd Receives Notice of Termination for COVID-19 EUA
2d ago
Newsfilter
Invivyd Grants Stock Options to New Employees
6d ago
Newsfilter
Invivyd Completes Enrollment in LIBERTY Clinical Trial for VYD2311
Jun 16 2026
Newsfilter
Invivyd Initiates Phase 3 Trial for VYD2311 Monoclonal Antibody
Jun 10 2026
NASDAQ.COM
Invivyd Launches LIBERTY Clinical Trial for VYD2311
Jun 09 2026
Newsfilter
Invivyd Grants Stock Options to New Employees
Jun 03 2026
Newsfilter
Invivyd's Q1 Revenue Misses Expectations, Shares Plummet
May 14 2026
stocktwits
Invivyd Q1 2026 Earnings Call Highlights
May 14 2026
seekingalpha
Invivyd Reports Q1 2026 Financial Results with Revenue Growth
May 14 2026
seekingalpha
Invivyd to Announce Q1 Earnings on May 14
May 13 2026
seekingalpha
Invivyd's Antibody Study Shows Low Side Effects
May 11 2026
Newsfilter
Invivyd Chairman to Speak at Health Summit
Apr 20 2026
Newsfilter
Invivyd Reports Progress in Late-Stage Trial for COVID-19 Therapy VYD2311
Apr 09 2026
seekingalpha
Invivyd Announces Progress in COVID-19 Study and New Measles Antibody Candidate
Apr 09 2026
Newsfilter
Show More News
